Your browser doesn't support javascript.
loading
Interaction with both domain I and III of albumin is required for optimal pH-dependent binding to the neonatal Fc receptor (FcRn).
Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Dalhus, Bjørn; Gunnarsen, Kristin Støen; Cameron, Jason; Grevys, Algirdas; Bunting, Karen; Sandlie, Inger; Andersen, Jan Terje.
Afiliación
  • Sand KM; From the Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0316 Oslo, Norway, CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway, P. O. Box 4950, N-0424 Oslo, Norway.
  • Bern M; From the Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0316 Oslo, Norway, CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway, P. O. Box 4950, N-0424 Oslo, Norway.
  • Nilsen J; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway, P. O. Box 4950, N-0424 Oslo, Norway, Institute of Clinical Medicine, University of Oslo, N-0424 Oslo, Norway.
  • Dalhus B; Department for Microbiology, Oslo University Hospital Rikshospitalet and University of Oslo, P. O. Box 4950, Nydalen, N-0424 Oslo, Norway, Department of Medical Biochemistry, Oslo University Hospital Rikshospitalet and University of Oslo, P. O. Box 4950, Nydalen, N-0424 Oslo, Norway, and Novozymes B
  • Gunnarsen KS; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway, P. O. Box 4950, N-0424 Oslo, Norway.
  • Cameron J; Novozymes Biopharma UK Ltd., Castle Court, 59 Castle Boulevard, NG7 1FD Nottingham, United Kingdom.
  • Grevys A; From the Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0316 Oslo, Norway, CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway, P. O. Box 4950, N-0424 Oslo, Norway.
  • Bunting K; Institute of Clinical Medicine, University of Oslo, N-0424 Oslo, Norway.
  • Sandlie I; From the Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0316 Oslo, Norway, CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway, P. O. Box 4950, N-0424 Oslo, Norway.
  • Andersen JT; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway, P. O. Box 4950, N-0424 Oslo, Norway, j.t.andersen@medisin.uio.no.
J Biol Chem ; 289(50): 34583-94, 2014 Dec 12.
Article en En | MEDLINE | ID: mdl-25344603
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Albúmina Sérica / Receptores Fc / Antígenos de Histocompatibilidad Clase I Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biol Chem Año: 2014 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Albúmina Sérica / Receptores Fc / Antígenos de Histocompatibilidad Clase I Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biol Chem Año: 2014 Tipo del documento: Article País de afiliación: Noruega